Tutorials
TSXV:NGEN (Canada)  
NervGen Pharma Corp logo

NervGen Pharma Corp

C$ 2.24 (+1.36%) Aug 9
P/E:
At Loss
P/B:
8.11
Market Cap:
C$ 131.14M ($ 101.75M)
Enterprise V:
C$ 118.31M ($ 91.79M)
Volume:
76.89K
Avg Vol (2M):
47.44K
Also Trade In:
Volume:
76.89K
Market Cap C$:
131.14M
Market Cap $:
101.75M
PE Ratio:
At Loss
Avg Vol (2-Month):
47.44K
Enterprise Value C$:
118.31M
Enterprise Value $:
91.79M
PB Ratio:
8.11
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

NervGen Pharma Corp
NAICS : 325412 SIC : 3741
2955 Virtual Way, Suite 480, Vancouver, BC, CAN, V5M 4X6
Description
NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer's disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.92
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 56.91
9-Day RSI 58.15
14-Day RSI 57.56
6-1 Month Momentum % -21.2
12-1 Month Momentum % -1.99

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12
Quick Ratio 12
Cash Ratio 11.46

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19.3
Name Current Vs Industry Vs History
ROE % -152.28
ROA % -137.5
ROIC % -3260.46
ROC (Joel Greenblatt) % -487031.25
ROCE % -153.64

Financials

TSXV:NGEN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 0
EPS (TTM) (C$) -0.36
Beta 1.53
Volatility % 49.69
14-Day RSI 57.56
14-Day ATR (C$) 0.163418
20-Day SMA (C$) 2.04
12-1 Month Momentum % -1.99
52-Week Range (C$) 1.52 - 3.33
Shares Outstanding (Mil) 58.54

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NervGen Pharma Corp Filings

Document Form Filing Date
No Filing Data